02.21.2023 - By Meryl Comer, UsAgainstAlzheimer's
Will 2023 be a boom or bust year for new Alzheimer’s drugs? In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School. Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s. Support the show